Onsdag 28 Oktober | 18:15:48 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Lifecare Q3 2023 - Injection of growth capital sets the stage for an eventful year

2023-11-15 08:35:00

Redeye expects an eventful 2024 for Lifecare following the Q3 report, which sported slightly higher revenues and lower costs than anticipated. We largely maintain our estimates and slightly increase our base case.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/